Cellmid secures China patent coverage for hair loss

Bio-technology developer Cellmid has secured patent coverage for its Evolis anti-ageing hair care and hair loss products in the potentially large China market. The Chinese Patent Office has issued notification of its grant of the patent “method of treatment of Alopecia with Monoterpenoids.” Monoterpenoids are a class of terpenes found in botanical extracts and formulated…

Orthocell receives $2.9 million R&D refund

Nerve technology developer Orthocell (ASX:OCC) has received a $2.9 million R&D tax incentive refund for the 2018/19 financial year. The Perth company, which is commercialising its CelGro product to facilitate the regeneration of severed peripheral nerves, will invest the funds to accelerate regulatory approvals and to advance R&D. The company also recently raised new capital…

Fonterra offloads pharmaceutical business, cuts debt

New Zealand dairy giant Fonterra (ASX: FSF) has offloaded its shareholding in pharmaceutical supplier DPE Pharma as it reorganises its businesses to cut debt. The company sold its 50 per cent shareholding in the international suppliier of dry inhalation powders for $589 million (NZD$633 million), ending its association with milk-based pharmaceuticals. The purchaser was capital…